# Hemab

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/hemab-aps

- Industry: Biotechnology
- Headquarters: Frederiksberg, Denmark
- Website: www.hemab.com
- Total disclosed funding: $347M
- Latest round: Series C (Oct 27, 2025)
- Investors on record: 11

## About

Founded in 2019, and based in Frederiksberg, Denmark, Hemab ApS is a biotechnology company dedicated to developing innovative therapeutics for serious bleeding and thrombotic disorders, addressing critical unmet medical needs in patient care.

## Funding rounds

- Series C, Oct 27, 2025, $157M — Sofinnova Partners, HealthCap, Novo Holdings, Access Industries, Maj Invest, Invus Financial Advisors, RA Capital Management, Rock Springs Capital, Avoro Capital Advisors, Deep Track Capital
- Series B, Feb 21, 2023, $135M — HealthCap, Novo Holdings, Access Industries, Maj Invest, Invus [DUP], RA Capital Management, Rock Springs Capital, Avoro Capital Advisors, Deep Track Capital
- Series A, Jul 22, 2021, $55M — HealthCap, Novo Holdings, RA Capital Management

## Investors

- HealthCap — Series A, Series B, Series C
- Novo Holdings — Series A, Series B, Series C
- RA Capital Management (https://capitalatlas.ai/funds/ra-capital-management) — Series A, Series B, Series C
- Access Industries (https://capitalatlas.ai/funds/access-industries) — Series B, Series C
- Maj Invest (https://capitalatlas.ai/funds/maj-invest) — Series B, Series C
- Invus [DUP] — Series B
- Rock Springs Capital — Series B, Series C
- Avoro Capital Advisors — Series B, Series C
- Deep Track Capital (https://capitalatlas.ai/funds/deep-track-capital) — Series B, Series C
- Sofinnova Partners (https://capitalatlas.ai/funds/sofinnova-partners) — Series C
- Invus Financial Advisors (https://capitalatlas.ai/funds/invus-financial-advisors) — Series C